Safety Study of Galantamine in Tic Disorders
Stopped early · Phase 4
Conditions studied: Tourette's Syndrome, Motor Tic Disorder, Vocal Tic Disorder
In brief
The purpose of this study is to determine the safety, tolerability and efficacy of galantamine in tic disorders. The impact of galantamine on commonly associated behaviors (i.e. attention, obsessions, etc.) will also be examined.
Key facts
- Study ID
- NCT00226824
- Run by
- Parkinson's Disease and Movement Disorders Center
- People needed
- 1
- Starts
- 2005-09-01
- Expected to finish
- 2007-05-01
- Last updated by the study team
- 2009-08-25
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- DSM IV criteria for the diagnosis of Tourette's syndrome, chronic motor or chronic vocal tic disorder
- Accepted method of birth control
You may not qualify if…
- Preganancy or nursing
- Unstable medical illness
- Unstable psychiatric illness
Where it is running
- Parkinson's Disease and Movement Disorders Center of Albany Medical Center — Albany, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.